Quit Paxil: Real Life Experiences
May 1, 2007 10:07

In 1999 when the owner of this website decided to quit Paxil, he went through extreme withdrawal. When he tried to find out information about his symptoms there was none so he put up a website. Soon other Paxil people found him and started posting their experiences... (Read Article)

FDA - MedWatch - Antidepressant Medications - FDA Proposes That Manufacturers Update Product Labeling To Include New Warnings About Suicidal Thinking and Behavior In Young Adults
May 3, 2007 06:12

Date: Wed, 2 May 2007 15:03:28 -0400
From: CDER MEDWATCH LISTSERV
Subject: FDA - MedWatch - Antidepressant Medications - FDA Proposes That Manufacturers Update Product Labeling To Include New Warnings About Suicidal Thinking and Behavior In Young Adults

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information for their products to include warnings about the increased risks of suicidal thinking and behavior in young adults ages 18 to 24 years old during the first one to two months of treatment. The proposed labeling changes also state that scientific data did not show this increased risk in adults older than 24 years of age and that adults 65 years of age and older taking antidepressants have a decreased risk of suicidality. The proposed updates apply to the entire category of antidepressants. Individuals currently taking prescribed antidepressant medications should not stop taking them and should notify their healthcare professional if they have concerns.
Manufacturers of antidepressant medications will have 30 days to submit their revised product labeling and revised Medication Guides to FDA for review. See the FDA press release for the list of products affected by the proposed antidepressant product labeling changes.